GeneMind

GeneMind Biosciences Company Limited (hereinafter referred to as "GeneMind") was founded in 2012, with its headquarters located in Luohu, Shenzhen. The company has over 8,000 square meters of working space, including R&D laboratories and GMP production lines.GeneMind consistently focuses on the independent research, development, and manufacturing of upstream molecular diagnostic technology platforms centered around gene sequencing instruments. It is committed to collaborating with a wide range of genetic testing service providers and medical institutions to build a precision medicine ecosystem that serves human life and health. GeneMind has launched two innovative self-developed sequencing platforms: GenoCare, a single-molecule sequencing platform, and GenoLab, a high-throughput sequencing platform. These provide an all-in-one platform solution encompassing "instruments-reagents-chips-software." The company owns nearly 200 technical patents registered in mainland China, Hong Kong, Europe, and the United States, making it one of the few hard-tech enterprises globally with core upstream gene sequencing technologies and an independent brand. Notably, GenoCare is the world's first single-molecule gene sequencer to have successfully completed clinical trials for medical devices.After years of dedicated efforts, GeneMind has mastered various key "bottleneck" technologies and processes of gene sequencing platforms locally in China. This includes the independent domestic R&D and production of core raw materials such as enzymes, nucleic acids, dyes, and chips, ensuring that these crucial tools are no longer reliant on foreign sources.